Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by SizzlinSteakson Nov 30, 2017 8:50am
65 Views
Post# 27061772

RE:Theralase® CLT, in combination with various standard cancer

RE:Theralase® CLT, in combination with various standard cancer So... since they are already approved by Health Canada for knee and muscular treatment would they need to make a seperate submission to Health Canada to use in precancer treatment? Just wondering the timeframe to get this implemeted into "standard practice". Anybody have an idea? 


ProOrbite wrote:

THIS GREAT NEWS is just astounding again! Gongrats once more Theralase!
Love this part of  the news release!

"3) Increase the efficacy of chemotherapy drugs, which can be used to lower the doses of chemotherapy drugs administered and potentially decrease their associated side effects.

Mark Roufaiel, Ph.D., Research Scientist, Theralase stated that, “CLT has been previously used successfully in cancer patients for the prevention and management of complications after surgery, chemotherapy and radiation therapy, but in general, it has been withheld by healthcare practitioners for fear that CLT might result in the stimulation or progression of cancerous tumors. The latest data discovered by our scientific team; however, strongly suggests that Theralase® CLT, at predefined scientifically determined doses is: safe, tolerable, effective and does not promote tumour growth, but on the contrary, delays tumour growth and increases overall patient survival. The latest data presented here further supports the potential for using Theralase® CLT, in combination with various standard cancer treatments to enhance cancer destruction and reduce their associated side effects. The fact that Theralase® CLT enhanced cancer cell death was demonstrated preclinically by using not one, but numerous anti-cancer treatments (i.e.: PDT, X-ray, Cisplatin or Temozolomide) strengthens the claim and supports the potential use of Theralase® CLT in numerous anti-cancer treatment programs. Theralase® CLT, and its reversal of the Warburg Effect, provides a powerful tool to be used by healthcare practitioners in the war on cancer, to pre-treat a patient, prior to anti-cancer treatment, to enhance the effectiveness of the treatment.”"




Bullboard Posts